History

Artielle ImmunoTherapeutics, Inc is a spin off from Virogenomics, Inc., a privately held biotechnology company. The business strategy of Virogenomics is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. To date, Virogenomics has obtained rights to technologies in three general disease areas including autoimmune diseases, infectious diseases, and stroke. The autoimmune technology was spun-off in 2004 as Artielle ImmunoTherapeutics.